Tacey X. Viegas

Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery

Tacey X. Viegas, Michael D. Bentley, J. Milton Harris et al. · Bioconjugate Chemistry · 2011 · 423 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications

Randall W. Moreadith, Tacey X. Viegas, Michael D. Bentley et al. · European Polymer Journal · 2016 · 173 citations

Medicine, Pharmacology, Drug Delivery +14

Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor

Anna Mero, Zhihao Fang, Gianfranco Pasut et al. · Journal of Controlled Release · 2012 · 80 citations

Medicine, Hematology, Pharmacology +6

Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit

Karen L. Eskow Jaunarajs, David G. Standaert, Tacey X. Viegas et al. · Movement Disorders · 2013 · 68 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

<scp>Once‐Weekly</scp> Subcutaneous Delivery of <scp>Polymer‐Linked</scp> Rotigotine (<scp>SER</scp>‐214) Provides Continuous Plasma Levels in Parkinson's Disease Patients

C. Warren Olanow, David G. Standaert, Karl Kieburtz et al. · Movement Disorders · 2020 · 53 citations

Medicine, Pharmacokinetics, Pharmacology +15